1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legislation

If At First You Don’t Succeed: VALID Act For Diagnostics Introduced In Congress For Third Time

 
• By Shawn M. Schmitt

The Verifying Accurate, Leading-edge IVCT Development (VALID) Act, which calls for a new regulatory framework for diagnostic tests, has been reintroduced in the US Congress.

US Capitol.

Legislation that calls for a new regulatory framework for diagnostic tests has been introduced in the US Congress – for the third time.

The Verifying Accurate, Leading-edge IVCT Development (VALID) Act was reintroduced on 24 June by Sens. Richard Burr, R-NC, and Michael Bennet, D-CO, and Reps. Diana DeGette, D-CO, and Larry...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

Debate On FDA User Fee Reauthorization Begins To Take Shape

 
• By Elizabeth Orr

A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.